Working Time
- Mon-Sat 08:00 – 20:00
Sunday On Appointment
Contact Info
-
Phone: +91 7780297660
Multiple Myeloma
Comprehensive Multiple Myeloma Treatment in Hyderabad
Multiple myeloma is a complex and heterogeneous disease with various subtypes that require specialized care and tailored treatment approaches. Dr. S. K. Gupta, a distinguished hematologist in Hyderabad, offers comprehensive multiple myeloma treatment services, utilizing advanced therapies and personalized care to address the unique needs of each patient. With his extensive expertise and commitment to excellence, Dr. Gupta ensures that patients receive the highest standard of care throughout their multiple myeloma journey.
Light Chain Myeloma:
Light chain myeloma, also known as Bence Jones myeloma, is a subtype of multiple myeloma characterized by the overproduction of abnormal light chains by plasma cells. Dr. Gupta specializes in diagnosing and treating light chain myeloma, employing targeted therapies and immunomodulatory agents to control the disease and improve patient outcomes.
Non-secretory Myeloma:
Non-secretory myeloma is a rare subtype of multiple myeloma in which the abnormal plasma cells do not produce detectable levels of monoclonal proteins (M proteins) in the blood or urine. Dr. Gupta has expertise in diagnosing and managing non-secretory myeloma, utilizing advanced imaging techniques and bone marrow biopsies to assess disease progression and guide treatment decisions.
Solitary Plasmacytoma:
Solitary plasmacytoma is a localized form of plasma cell neoplasm that typically affects a single bone or soft tissue site. Dr. Gupta offers specialized treatment options for solitary plasmacytoma, including radiation therapy, surgery, and targeted therapies, to achieve local control and prevent disease recurrence.
Extramedullary Plasmacytoma:
Extramedullary plasmacytoma is a rare form of plasma cell neoplasm that arises outside the bone marrow, often in soft tissues or organs. Dr. Gupta is experienced in diagnosing and managing extramedullary plasmacytoma, utilizing a multidisciplinary approach to tailor treatment plans to each patient’s specific needs and preferences.
Monoclonal Gammopathy of Undetermined Significance (MGUS):
Monoclonal gammopathy of undetermined significance (MGUS) is a condition characterized by the presence of abnormal monoclonal proteins in the blood, without evidence of multiple myeloma or other plasma cell disorders. Dr. Gupta provides expert evaluation and monitoring of MGUS patients, assessing the risk of progression to symptomatic disease and implementing appropriate surveillance strategies.
Smoldering Multiple Myeloma (SMM):
Smoldering multiple myeloma (SMM) is an asymptomatic precursor condition characterized by the presence of abnormal plasma cells in the bone marrow and elevated levels of monoclonal proteins in the blood or urine. Dr. Gupta offers specialized care for patients with SMM, monitoring disease progression and implementing early intervention strategies to delay or prevent the development of symptomatic myeloma.
Immunoglobulin D (IgD) Myeloma:
Immunoglobulin D (IgD) myeloma is a rare subtype of multiple myeloma characterized by the production of abnormal IgD monoclonal proteins by plasma cells. Dr. Gupta has expertise in diagnosing and managing IgD myeloma, utilizing targeted therapies and immunomodulatory agents to control disease activity and improve patient outcomes.
Immunoglobulin E (IgE) Myeloma:
Immunoglobulin E (IgE) myeloma is another rare subtype of multiple myeloma characterized by the production of abnormal IgE monoclonal proteins by plasma cells. Dr. Gupta offers specialized care for patients with IgE myeloma, employing tailored treatment approaches to address the unique biological features of the disease and optimize therapeutic outcomes.
Dr. S. K. Gupta, Expert Hematologist in Hyderabad
Dr. S. K. Gupta is a highly regarded hematologist with a wealth of experience in treating multiple myeloma and other hematologic malignancies. A gold medalist in his field, Dr. Gupta holds MBBS, MD, and DM degrees from AIIMS Delhi, as well as a fellowship in leukemia/BMT/CAR T cells from UBC, Canada. Committed to providing compassionate, patient-centered care, Dr. Gupta combines his expertise with a personalized approach to ensure the best possible outcomes for his patients.
Why Choose Us?
- Expertise: Dr. Gupta is recognized as one of the best hematologists in Hyderabad, known for his expertise in multiple myeloma treatment and management.
- Personalized Care: Each patient receives individualized treatment plans tailored to their specific subtype of multiple myeloma, disease stage, and overall health status.
- Advanced Therapies: Our clinic offers access to the latest advancements in multiple myeloma treatment, including novel targeted therapies, immunomodulatory agents, and stem cell transplantation.
- Comprehensive Support: We provide comprehensive support services, including patient education, emotional support, and symptom management, to ensure patients and their families feel supported and informed throughout their treatment journey.
For expert care and compassionate support in the treatment of multiple myeloma or any other hematologic malignancy, trust Dr. S. K. Gupta, the leading hematologist in Hyderabad. Contact us today to schedule a consultation and take the first step towards remission and recovery.
Risk factors for multiple myeloma may include age, gender, family history, exposure to certain chemicals or radiation, obesity, and certain genetic abnormalities.
Diagnosis typically involves a combination of blood tests, urine tests, imaging studies (such as X-rays, CT scans, or MRI), bone marrow biopsy, and genetic testing to confirm the presence of abnormal plasma cells and determine the subtype and stage of the disease.
Treatment options for multiple myeloma may include chemotherapy, targeted therapy, immunotherapy, radiation therapy, stem cell transplantation, or a combination of these approaches, depending on the subtype and stage of the disease.